Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Stocks News & Analysis
stocks
Ask the analyst: Can this genius product create the next ASX software king?
stocks
Impact of ANZ’s huge fine
stocks
Acquisition a sign of weakness for overvalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,094.90 | 27.60 | -0.30% |
CAC 40 | 7,809.02 | 9.20 | -0.12% |
DAX 40 | 23,426.28 | 97.04 | 0.42% |
Dow JONES (US) | 46,017.53 | 259.63 | 0.57% |
FTSE 100 | 9,242.77 | 47.11 | 0.51% |
HKSE | 26,908.39 | 469.88 | 1.78% |
NASDAQ | 22,262.90 | 71.06 | -0.32% |
Nikkei 225 | 44,790.38 | 111.89 | -0.25% |
NZX 50 Index | 13,228.38 | 6.51 | -0.05% |
S&P 500 | 6,603.65 | 3.11 | -0.05% |
S&P/ASX 200 | 8,818.50 | 30.00 | -0.34% |
SSE Composite Index | 3,876.34 | 14.48 | 0.37% |